Work

TBCRC 036: Window of opportunity clinical trial reveals adaptive kinome reprogramming in single and combination HER2-targeting in breast cancer (BrCa).

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.1027

Authors: Steven P Angus, Timothy Stuhlmiller, Noah Sciaky, Xin Chen, Rashid Naim, Maki Tanioka, Kristalyn K. Gallagher, Andres Forero, Ian E. Krop, Alastair Mark Thompson, Rashmi Krishna Murthy, Xiaping He, Charles M. Perou, Shelton Earp, Lisa A. Carey, Gary L. Johnson

Institutions: University of North Carolina at Chapel Hill, University of Arkansas for Medical Sciences, University of Alabama at Birmingham, Dana-Farber Cancer Institute, The University of Texas MD Anderson Cancer Center, UNC Lineberger Comprehensive Cancer Center

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2623615300

Cites:

Cited by:

Related to: 10